The attenuation in PTHrP-mediated increase in serum Ca2+, as observed in parathyroidectomized rats in which hypercalcemia had been induced with PTHrP injections, resulted from increased secretion of calcitonin and suggests calcimimetics didn't act directly on the tumor cells (67, 68). Here, PTHLH is linked to hypercalcemia disease.